Literature DB >> 26179925

Tissue Characterization of In-Stent Neointima Using Optical Coherence Tomography in the Late Phase After Bare-Metal Stent Implantation--An Ex Vivo Validation Study.

Masahiko Shibuya1, Kenichi Fujii, Hiroyuki Hao, Takahiro Imanaka, Ten Saita, Masashi Fukunaga, Kojiro Miki, Hiroto Tamaru, Machiko Nishimura, Tetsuo Horimatsu, Yoshiro Naito, Hatsue Ishibashi-Ueda, Seiichi Hirota, Tohru Masuyama.   

Abstract

BACKGROUND: We performed an ex vivo study to investigate optical coherence tomography (OCT) imaging for differentiating several types of neointimal tissue during the later phases after bare-metal stent (BMS) implantation as compared with histologic results. METHODS AND 
RESULTS: OCT imaging was performed in 6 autopsy hearts for 10 BMS with implant duration >4 years. OCT qualitative neointimal tissue characterization was based on tissue structure and classified as homogeneous pattern, heterogeneous pattern with visible struts, or heterogeneous pattern with invisible struts. Corresponding histological analyses of each 2-mm cross-section of the entire BMS were performed. Of 81 cross-sections, histological analysis revealed that the homogeneous pattern of neointima on OCT (n=39) contained smooth muscle cells with collagen, indicating high neointimal maturity. The heterogeneous patterns with visible struts (n=35) contained different tissues, including a proteoglycan-rich myxomatous matrix or dense calcified plate deposition. The heterogeneous patterns with invisible struts (n=7) included neointimal lipid/necrotic core formation, accumulation of foam cells, or microcalcification scattering. Of the 66 cross-sections containing large microvessels within the neointima on histology, only 6 (9%) were visualized by OCT.
CONCLUSIONS: The present study confirmed the potential use of OCT in differentiating several types of neointima after BMS implantation. The image interpretation of OCT, based on visualization of stent struts, enables identification of several types of neointimal tissues, including in-stent fibroatheroma formation, more accurately.

Entities:  

Mesh:

Year:  2015        PMID: 26179925     DOI: 10.1253/circj.CJ-15-0585

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  5 in total

1.  Neointimal tissue characterization after implantation of drug-eluting stents by optical coherence tomography: quantitative analysis of optical density.

Authors:  Setsu Nishino; Masashi Sakuma; Tomoaki Kanaya; Takahisa Nasuno; Michiaki Tokura; Shigeru Toyoda; Shichiro Abe; Daisuke Nakamura; Kentaro Tanaka; Guiherme F Attizzani; Hiram G Bezerra; Marco A Costa; Teruo Inoue
Journal:  Int J Cardiovasc Imaging       Date:  2019-06-19       Impact factor: 2.357

2.  Impact of optical coherence tomography- and coronary angioscopy-assessed neointimal tissue characteristics on occurrence of periprocedural myonecrosis in patients with in-stent restenosis.

Authors:  Shigeki Kimura; Tomoyo Sugiyama; Keiichi Hishikari; Shun Nakamura; Shun Nakagama; Toru Misawa; Masafumi Mizusawa; Kazuto Hayasaka; Yosuke Yamakami; Yuichiro Sagawa; Keisuke Kojima; Hirofumi Ohtani; Hiroyuki Hikita; Atsushi Takahashi; Mitsuaki Isobe
Journal:  Int J Cardiovasc Imaging       Date:  2016-07-16       Impact factor: 2.357

3.  Late neointimal volume reduction is observed following biodegradable polymer-based drug eluting stent in porcine model.

Authors:  Takeshi Ijichi; Gaku Nakazawa; Sho Torii; Hirofumi Nagamatsu; Ayako Yoshikawa; Shintaro Nakamura; Junko Souba; Atsushi Isobe; Hitomi Hagiwara; Yuji Ikari
Journal:  Int J Cardiol Heart Vasc       Date:  2021-05-11

Review 4.  Current clinical applications of coronary optical coherence tomography.

Authors:  Teruyoshi Kume; Shiro Uemura
Journal:  Cardiovasc Interv Ther       Date:  2017-07-14

5.  Open-Label Multicenter Registry on the Outcomes of In-Stent Restenosis Treated by Balloon Angioplasty with Optical Frequency Domain Imaging in the Superficial Femoral Artery (ISLAND-SFA Study).

Authors:  Kenichi Yanaka; Akihide Konishi; Toshiro Shinke; Amane Kozuki; Hiroyuki Kawamori; Yoshiro Tsukiyama; Osamu Iida; Makoto Kadotani; Takashi Omori; Ken-Ichi Hirata
Journal:  Ann Vasc Dis       Date:  2020-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.